Effects of Fingolimod on Heart Rhythm and Heart Rate Variability in Patients With Multiple Sclerosis

NCT03216915 · clinicaltrials.gov ↗

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Gilenya®; Novartis Pharmaceuticals Corporation

Sponsor

Universitätsklinikum Hamburg-Eppendorf